Atlas Trials

A Randomized Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy Decision-Making in High-Risk Stage III (T4N+ or T1-3N2) Colorectal Cancer

Clinical trial NCT07562490 · RECRUITING

Trial details

NCT number
NCT07562490
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
ctDNAChemotherapyColorectal Cancer
Start date
2025-04-01
Primary completion
2027-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.